Innovator’s Pitch Challenge – Finalists Announced!

November 4, 2021November 4, 2021 ~ Next Phase Admin ~ Leave a comment

By Gregory Mannix, Vice President International Business Development, General Manager Europe, LSN

At Digital RESI November we will again be showcasing top technologies across Drugs, Devices, Diagnostics and Digital Health in this edition of the Innovator’s Pitch Challenge. These companies will be featured on the RESI Live Agenda and will participate in live Pitch Sessions focused on a particular sector or indication, fielding questions from a panel of selected investors and industry experts. The IPC has grown tremendously in popularity over the past year and attracts a big virtual audience, including investors and strategic partners.

Best of luck to the finalists!!

The Future ETF of Early-Stage Investments

November 4, 2021June 15, 2022 ~ Next Phase Admin ~ Leave a comment

By Rory McCann, Marketing Manager & Conference Producer, LSN

KYTO Technology & Life Science is not your typical investment firm. They have a unique model that focuses on the financial investment, mentorship and advising, as well as growth and success of early-stage life science technology and their founding teams. Tom Vogelsong is the Director of Deal Flow and he sat down to discuss what makes KYTO’s outlook and processes different, the unique value they add to their portfolio, and exciting developments in the works.

KYTO is a frequent attendee and valuable asset to the RESI community. Get to know Tom and the team at Digital RESI November 16-18. Partnering is open, but there’s still time to sign up and book meetings! Register today to jumpstart your fundraising.

Last Day to Save

October 28, 2021 ~ Next Phase Admin ~ Leave a comment

By Karen Deyo, Director of Investor Research, Israel BD, LSN

Life Science Nation’s next event, Digital RESI November, is fast approaching, and with early bird pricing ending this Friday, now is the time to register if you haven’t already. Whether a first-time attendee or a familiar face, RESI offers many opportunities to advance your startup. From panels featuring investors and strategic partners providing insights into how they are best approached, to entrepreneurs sharing their fundraising success stories, to service providers providing tips on how to navigate the complex path to market based on decades of experience, RESI provides opportunities for seasoned entrepreneurs and first-time founders.

What makes RESI truly unique is the match-based partnering infrastructure and free education around how to make the system work in your favor to connect with partners who are a fit for your product and stage of development. RESI’s powerful ability to bring together the early-stage life science ecosystem and to provide companies and investors with a way to tailor their meetings to ensure the most effective use of their time makes it stand out at a time when virtual events are a dime-a-dozen. Don’t believe us? Check out the list of attending investors below. The partnering system is open, so make sure to register soon!

Confirmed Digital RESI November Investors and Strategic Partners

As of October 28

Applications Due Tomorrow

October 28, 2021October 28, 2021 ~ Next Phase Admin ~ Leave a comment

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

The Innovator’s Pitch Challenge (IPC) is a highlight at Life Science Nation events, with innovative startups in life science and healthcare pitching to investors in a live Q&A format, providing feedback, practice, and for some, valuable connections that lead to deals. The IPC returns to Digital RESI November 16-18 and there is one day left to apply at the extended deadline!

If you are involved with a company in active fundraising mode and want to boost your exposure, gain valuable feedback from investors and industry experts, and secure meetings with investors who have a genuine interest in your technology, you do not want to miss out on the last IPC of 2021!

Below is a list of companies who have been accepted as finalists – conference attendees will be able to vote for their favorite pitch.

Pain Points and the Power of Perseverance: The MindLab Story

October 28, 2021June 15, 2022 ~ Next Phase Admin ~ Leave a comment

By Rory McCann, Marketing Manager & Conference Producer, LSN

Larry Raoul James is no stranger to challenge, rejection, and powering through. His company, MindLab has developed a pain management therapeutic designed to prevent tolerance, dependence, and addiction in patients, while sustaining current efficacy standards. With recent endorsement from the US Army Medical Research & Development Command (a connection made through a recent RESI conference), Larry and the MindLab team are not slowing down. Despite the challenges associated with bringing novel therapeutics to market, they are working hard to meet a persistent and growing need for safe alternatives to pain medication.

Listen to a recent interview with Larry on the MindLab journey.

Tomorrow is the last day to sign up for Digital RESI November 16-18 at early bird rates. Sign up today to get started and save $100!

Automating Cancer Imaging Analysis – Interview with Joe Camaratta, President & CEO of Quantaras

October 26, 2021June 15, 2022 ~ Next Phase Admin ~ Leave a comment

By Erika Wu, Business Development Representative, LSN

Earlier this year, Quantaras (formerly known as Quantitative Radiology Solutions, QRS) received 510(k) clearance from the FDA and is now actively launching their AI-based technology to healthcare providers in the United States. Tune in and learn how Joe Camaratta, President & CEO of Quantaras, and his team are revolutionizing personalized cancer treatment decisions with the automation of medical imaging analysis. Digital RESI November (16-18) returns with dynamic panels, as well as opportunities to pitch to a live panel of investors. Learn more about how you can get involved and tell your story at November’s Innovator’s Pitch Challenge!

Innovator’s Pitch Challenge Applications Due Tomorrow

October 21, 2021 ~ Next Phase Admin ~ Leave a comment

By Megan Rychwa, Investor Research Analyst, LSN

Life Science Nation’s last conference of the year, Digital RESI November 16-18, is currently accepting applications from startup companies across the globe for the popular Innovator’s Pitch Challenge (IPC). The number of participating startups has doubled within the last year, with hundreds of companies and investors experiencing the value firsthand. Applications are accepted on a rolling basis until Friday, October 22.

The Innovator’s Pitch Challenge is an opportunity for early-stage companies to pitch to a live panel of investors within their sector. Each company’s marketing materials are highlighted on their dedicated webpage, as well as their recorded pitch, which investors can see prior to the conference in preparation for the live event. The pitch session is a unique chance for companies to gain exposure to a large investor audience and prepare those companies to build strategic partnerships with well-matched investors. The cost for IPC finalists includes event registration, as well as a $500 pitch fee.

The deadline for IPC applications is tomorrow, so make sure your application is in and you don’t miss out on this great opportunity to tell your story!